Navigation Links
Boston Scientific's Alair® Bronchial Thermoplasty System Achieves Important Reimbursement Milestones
Date:1/4/2012

vary materially from the expectations and projections expressed or implied by our forward-looking statements.  These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release.  As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements. 

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and future business decisions made by us and our competitors.  All of these factors are difficult or impossible to predict accurately and many of them are beyond our control.  For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A – Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A – Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter.  We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.  This cautionary statement is applicable to all forward-looking statements contained in this document.

CONTACT:   

Eric Olson
336-293-4393 (office)
Media Relations
Boston Scientific Corporation

SOURCE Boston Scientific
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Mass. , May 21, 2013 /PRNewswire/ ... research and advisory firms for pharmaceutical and ... an emerging agent on key efficacy endpoints, ... progression, has the most influence over surveyed ... advanced/metastatic hormone-receptor (HR-) positive, HER2-negative breast cancer. ...
(Date:5/21/2013)... , May 21, 2013 iHealth ... manufacture of wireless personal healthcare products and a ... reach, announcing the release of two new fitness ... pressure monitors and scales: the Wireless Pulse Oximeter ... (Photo: http://photos.prnewswire.com/prnh/20130521/SF17618 ) iHealth ...
(Date:5/21/2013)... Md. , May 21, 2013 ... disposable drug-free consumer electronic devices, announced that CEO, ... presenting today to the FDA,s Medical Advisory Committee, ... the company,s products for over the counter sales. ... FDA developed its medical device classification schema," Whelan ...
Breaking Medicine Technology:Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2iHealth Lab adds new products and partners to mobile personal healthcare offering 2iHealth Lab adds new products and partners to mobile personal healthcare offering 3BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3
... Calif. and FORT WASHINGTON, Pa., Oct. 19, 2011 ... and fitness measurement utilizing biometric testing devices and ... in consumer focused, health engagement digital messaging, today ... solutions in the retail and non-retail markets. ...
... ATLANTA, Oct. 19, 2011 VaxyGen ... of an exclusive license and collaboration agreement with ... VaxyGen the exclusive license to a novel patent ... biopharmaceutical and vaccine products. In addition, VaxyGen and ...
Cached Medicine Technology:ADFLOW Health Networks and Stayhealthy Form Strategic Partnership to Deploy the Most Comprehensive Biometric Screening and Consumer Health Engagement Platform in U.S. 2ADFLOW Health Networks and Stayhealthy Form Strategic Partnership to Deploy the Most Comprehensive Biometric Screening and Consumer Health Engagement Platform in U.S. 3ADFLOW Health Networks and Stayhealthy Form Strategic Partnership to Deploy the Most Comprehensive Biometric Screening and Consumer Health Engagement Platform in U.S. 4VaxyGen Manufacturing Services LLC Announces Exclusive License and Collaborative Agreement with Georgia State University Research Foundation to Commercialize Novel Biological Process Development Patent, Expertise & Know-How 2VaxyGen Manufacturing Services LLC Announces Exclusive License and Collaborative Agreement with Georgia State University Research Foundation to Commercialize Novel Biological Process Development Patent, Expertise & Know-How 3
(Date:5/21/2013)... (PRWEB) May 21, 2013 Phoseon Technology ... at the 20th Annual IMI European Ink Jet ... proven market leader, Phoseon continues to invest in product ... the adoption of UV LED curing in printing applications. ... families on the market offering both air cooled and ...
(Date:5/21/2013)... Global Proving Ground (GPG), a fast rising ... retailer of health and fitness supplements, are partnering up ... Island. “We cast the show by having millions ... our unique social networking platform,” states show’s creator James ... an island in the Pacific Ocean, where they must ...
(Date:5/21/2013)... Texas (PRWEB) May 21, 2013 ... With the help of Texas Counseling’s Sexuality and ... communication, and the development of healthier habits for ... workshops available for both couples and individuals at ... enhance their relationships and learn skills to develop ...
(Date:5/21/2013)... the roles two proteins, thrombospondin-1 and prosaposin, play ... has identified a five-amino acid fragment of prosaposin ... of prostate, breast and lung cancer. The findings ... metastasis in a variety of cancers. , ... at Boston Children,s Hospital, Vivek Mittal, PhD, at ...
(Date:5/21/2013)... University of Cincinnati (UC) researchers have identified a number ... help with earlier diagnosis and intervention in those who ... first of its kind and led by UC,s Bruce ... staff from Walter Reed National Military Medical Center at ... Orlando, Fla. , The DoDSR is a biological ...
Breaking Medicine News(10 mins):Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3Health News:Workshops Offered To Identify Underlying Challenges That Put Strain On Relationships 2Health News:Changing cancer's environment to halt its spread 2Health News:Changing cancer's environment to halt its spread 3Health News:Biomarkers discovered for inflammatory bowel disease 2
... , , BOULDER, Colo., July 30 ... owning patented surgical technology that is emerging as a standard of ... quarter of fiscal year 2010. , , Net ... representing a 3% increase over net sales of $3.1 million for ...
... , SAO PAULO, July 30 Frost & Sullivan ... recipient of the 2009 Market Penetration Leadership Award ... offers a complete portfolio of solutions including digital and computed radiography, ... by the needs of customers willing to enter in the digital ...
... , , CHICAGO, July ... the world,s largest scientific/medical society dedicated to advancing research and ... of the human lifespan, unveils an innovative, technology-based fix to ... Increase the lifespan, or improve the healthspan, of all ...
... ... America, will award prizes to young filmmakers, 25 years of age and under, ... America. The top three winners will receive cash prizes of $5,000, $3,500 and ... 5-12 minutes creative films online, where the public will partake in the first ...
... ... provide students with an excellent option for a less expensive education in the thriving ... ... the nursing shortage creates opportunity for the qualified nurse, and online nursing degrees are ...
... DALLAS July 30, 2009 The typical dose ... is much too low to account for modern-day physiques, ... The finding, reported online and in the August edition ... important for those living in societies plagued by obesity, ...
Cached Medicine News:Health News:Encision Reports Profitable First Fiscal Quarter Results 2Health News:Encision Reports Profitable First Fiscal Quarter Results 3Health News:Encision Reports Profitable First Fiscal Quarter Results 4Health News:Frost & Sullivan Awards Agfa Healthcare for Brazilian Market Penetration Leadership in 2009 2Health News:Frost & Sullivan Awards Agfa Healthcare for Brazilian Market Penetration Leadership in 2009 3Health News:Obama White House Can Save $3.7 Trillion and Extend Lifespan 29+ Years, Predicts Revolutionary A4M Healthcare Plan 2Health News:Call to the Youth of America: Palms for Life Fund Launches Film Competition to Document Hunger in the United States 2Health News:All Nursing Schools Sheds Light on Online Nursing Degree Opportunities in a Rough Economy 2Health News:Higher drug doses needed to defeat tuberculosis, UT Southwestern researchers report 2Health News:Higher drug doses needed to defeat tuberculosis, UT Southwestern researchers report 3
... Mumps IgM Enzyme-Linked Immunosorbent Assay ... qualitative detection of IgM antibody ... for the determination of immunological ... this kit have not been ...
The DSL 05-10-MUM Mumps IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Mumps virus in human serum. This assay is intended for in...
... announced the launch of the Chilli ... bi-directional cooled-tip catheter available in the United ... physicians the benefits of cooled ablation technology ... Boston Scientific Blazer(R) catheter platform. ,Cooled cardiac ...
... wire crosses the lesion first, independent of ... actions, including filter placement and retrieval, balloon ... the wire., ,Emboshield is designed to capture ... carotid stenting procedure, and it is the ...
Medicine Products: